Tactile Systems (TCMD) | Financial Analysis & Statements
Tactile Systems Technology Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
103.6M
Gross Profit
81.0M
78.20%
Operating Income
18.8M
18.12%
Net Income
10.6M
10.27%
EPS (Diluted)
$0.46
Balance Sheet Metrics
Total Assets
273.9M
Total Liabilities
55.0M
Shareholders Equity
218.9M
Debt to Equity
0.25
Cash Flow Metrics
Operating Cash Flow
13.6M
Free Cash Flow
16.7M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Tactile Systems Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 329.5M | 293.0M | 274.4M | 246.8M | 208.1M |
| Cost of Goods Sold | 79.4M | 76.3M | 79.3M | 70.8M | 59.8M |
| Gross Profit | 250.1M | 216.7M | 195.1M | 176.0M | 148.2M |
| Gross Margin % | 75.9% | 74.0% | 71.1% | 71.3% | 71.2% |
| Operating Expenses | |||||
| Research & Development | 8.5M | 8.8M | 7.8M | 7.1M | 5.7M |
| Selling, General & Administrative | 209.9M | 183.1M | 169.2M | 167.2M | 143.6M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 218.4M | 192.0M | 177.0M | 174.3M | 149.2M |
| Operating Income | 29.3M | 22.2M | 18.0M | -12.8M | -1.8M |
| Operating Margin % | 8.9% | 7.6% | 6.6% | -5.2% | -0.8% |
| Non-Operating Items | |||||
| Interest Income | 3.1M | 3.4M | - | - | - |
| Interest Expense | 1.0M | 2.1M | - | - | - |
| Other Non-Operating Income | 1.0K | 9.0K | -2.3M | -2.7M | -531.0K |
| Pre-tax Income | 31.3M | 23.5M | 15.8M | -15.5M | -2.3M |
| Income Tax | 12.3M | 6.5M | -12.7M | 2.4M | 9.5M |
| Effective Tax Rate % | 39.1% | 27.8% | -80.8% | 0.0% | 0.0% |
| Net Income | 19.1M | 17.0M | 28.5M | -17.9M | -11.8M |
| Net Margin % | 5.8% | 5.8% | 10.4% | -7.2% | -5.7% |
| Key Metrics | |||||
| EBITDA | 39.0M | 32.4M | 24.5M | 1.7M | 1.9M |
| EPS (Basic) | $0.83 | $0.71 | $1.24 | $-0.89 | $-0.60 |
| EPS (Diluted) | $0.82 | $0.70 | $1.23 | $-0.89 | $-0.60 |
| Basic Shares Outstanding | 22872841 | 23883729 | 22925497 | 20067969 | 19719485 |
| Diluted Shares Outstanding | 22872841 | 23883729 | 22925497 | 20067969 | 19719485 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Tactile Systems Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 83.4M | 94.4M | 61.0M | 21.9M | 28.2M |
| Short-term Investments | 15.8M | 14.5M | 14.2M | 16.1M | 12.5M |
| Accounts Receivable | 43.9M | 44.9M | 43.2M | 54.8M | 49.5M |
| Inventory | 14.0M | 18.7M | 22.5M | 23.1M | 19.2M |
| Other Current Assets | 8.1M | 5.1M | 4.4M | 3.8M | 4.1M |
| Total Current Assets | 165.2M | 177.6M | 145.3M | 119.8M | 113.5M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 25.4M | 27.5M | 29.0M | 34.0M | 35.2M |
| Goodwill | 101.3M | 104.9M | 108.8M | 112.5M | 116.2M |
| Intangible Assets | 39.2M | 42.8M | 46.7M | 50.4M | 54.1M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 19.6M | 24.3M | 33.0M | 26.4M | 14.8M |
| Total Non-Current Assets | 108.8M | 120.4M | 136.1M | 135.2M | 130.7M |
| Total Assets | 273.9M | 297.9M | 281.4M | 255.0M | 244.3M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 5.0M | 5.6M | 6.7M | 10.0M | 5.0M |
| Short-term Debt | 3.2M | 5.9M | 5.8M | 5.5M | 5.5M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 3.5M | 3.1M | 4.5M | 20.2M | 6.6M |
| Total Current Liabilities | 41.0M | 40.7M | 41.1M | 64.3M | 34.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 12.8M | 39.2M | 44.6M | 66.8M | 75.1M |
| Deferred Tax Liabilities | - | - | - | 0 | 32.0K |
| Other Non-Current Liabilities | - | - | - | - | 3.0M |
| Total Non-Current Liabilities | 14.1M | 40.6M | 46.7M | 69.3M | 81.6M |
| Total Liabilities | 55.0M | 81.3M | 87.8M | 133.6M | 116.0M |
| Equity | |||||
| Common Stock | 22.0K | 24.0K | 24.0K | 20.0K | 20.0K |
| Retained Earnings | 54.9M | 35.9M | 18.9M | -9.6M | 8.2M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 218.9M | 216.6M | 193.6M | 121.4M | 128.2M |
| Key Metrics | |||||
| Total Debt | 16.0M | 45.1M | 50.4M | 72.2M | 80.6M |
| Working Capital | 124.2M | 136.9M | 104.2M | 55.4M | 79.1M |
Balance Sheet Composition
Tactile Systems Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 19.1M | 17.0M | 28.5M | -17.9M | -11.8M |
| Depreciation & Amortization | 6.6M | 6.8M | 6.5M | 6.3M | 3.7M |
| Stock-Based Compensation | 8.4M | 7.8M | 7.5M | 9.6M | 10.2M |
| Working Capital Changes | 3.6M | 10.4M | 21.8M | -15.7M | -10.7M |
| Operating Cash Flow | 46.2M | 43.0M | 42.6M | -5.9M | 1.4M |
| Investing Activities | |||||
| Capital Expenditures | -2.4M | -2.4M | -2.3M | -1.8M | -2.1M |
| Acquisitions | - | - | 0 | 0 | -79.8M |
| Investment Purchases | - | - | - | - | 0 |
| Investment Sales | - | - | - | 0 | 0 |
| Investing Cash Flow | -2.4M | -2.4M | -2.3M | -1.8M | -81.9M |
| Financing Activities | |||||
| Share Repurchases | -26.6M | -3.5M | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 0 | 8.2M | 0 | 55.0M |
| Debt Repayment | -26.2M | -3.0M | -28.0M | -6.0M | 0 |
| Financing Cash Flow | -52.8M | -6.5M | 4.2M | -11.0M | 78.6M |
| Free Cash Flow | 40.3M | 38.1M | 33.4M | 3.3M | 276.0K |
| Net Change in Cash | -9.0M | 34.1M | 44.4M | -18.7M | -1.9M |
Cash Flow Trend
Tactile Systems Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
30.45
Forward P/E
16.93
Price to Book
2.56
Price to Sales
1.72
PEG Ratio
1.74
Profitability Ratios
Profit Margin
5.79%
Operating Margin
18.12%
Return on Equity
8.77%
Return on Assets
6.40%
Financial Health
Current Ratio
4.03
Debt to Equity
7.29
Beta
0.99
Per Share Data
EPS (TTM)
$0.82
Book Value per Share
$9.76
Revenue per Share
$14.41
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| TCMD | 556.2M | 30.45 | 2.56 | 8.77% | 5.79% | 7.29 |
| Abbott Laboratories | 160.7B | 25.97 | 3.09 | 12.36% | 13.90% | 26.79 |
| Stryker | 126.3B | 39.21 | 5.62 | 15.08% | 12.92% | 72.97 |
| Axogen | 1.9B | -110.18 | 13.15 | -13.49% | -6.97% | 55.50 |
| Establishment Labs | 1.9B | -37.89 | 79.68 | -133.25% | -24.19% | 1,123.15 |
| Artivion | 1.8B | 179.71 | 4.03 | 2.70% | 2.21% | 57.67 |
Financial data is updated regularly. All figures are in the company's reporting currency.






